Quarterly report [Sections 13 or 15(d)]

Stockholders??? Equity (Deficit) (Details)

v3.25.1
Stockholders’ Equity (Deficit) (Details) - USD ($)
1 Months Ended 3 Months Ended
Jul. 11, 2023
Jul. 31, 2021
Mar. 31, 2025
Feb. 18, 2025
Dec. 31, 2024
Dec. 19, 2024
Dec. 18, 2024
Dec. 11, 2024
Oct. 31, 2024
Oct. 09, 2024
Aug. 14, 2024
Jul. 29, 2024
Jul. 25, 2024
Jul. 23, 2024
Jul. 05, 2024
Jun. 25, 2024
Mar. 26, 2024
Stockholders’ Equity (Deficit) [Line Items]                                  
Common stock, shares authorized     400,000,000   400,000,000                        
Common stock, par value (in Dollars per share)     $ 0.001   $ 0.001                        
Common stock share issued     119,749,743   113,842,364                        
Common stock price (in Dollars per share)   $ 5 $ 1,000                            
Shares of common stock 43,649   736,773                            
Convertible debt shares granted     184,193                            
Warrant [Member]                                  
Stockholders’ Equity (Deficit) [Line Items]                                  
Shares warrants   4,000,000                              
Common stock price (in Dollars per share)   $ 0.0125                              
Warrants term   5 years 5 years                            
Exercise price per warrant (in Dollars per share)   $ 6 $ 6                            
Purchase of additional warrants   600,000                              
Proceeds of warrants (in Dollars)   $ 7,500                              
Common Stock [Member]                                  
Stockholders’ Equity (Deficit) [Line Items]                                  
Common stock price (in Dollars per share)   $ 4.99                              
Conversion of the shares series preferred stock 19,516,205                                
Series A-2 Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) [Line Items]                                  
Common stock share issued               4,624,551   5,500,000 3,502,000 1,359,000 3,756,000 3,550,000   5,956,000 2,850,000
Conversion of the shares series preferred stock 43,649             2,266.03   2,695 1,715.98 665.91 1,840.44 1,739.5   2,918.44 1,396.5
Series B-2 Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) [Line Items]                                  
Common stock share issued           3,003,000 1,441,000   438,000           42,118,000    
Conversion of the shares series preferred stock           3,003 1,441   438           7,882    
Series A-2 Prime Preferred Stock [Member]                                  
Stockholders’ Equity (Deficit) [Line Items]                                  
Common stock share issued       1,400,000                          
Conversion of the shares series preferred stock       686                          
IPO [Member]                                  
Stockholders’ Equity (Deficit) [Line Items]                                  
Common stock share issued   5,000,000